SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001169245-21-000112
Filing Date
2021-11-09
Accepted
2021-11-09 20:46:54
Documents
1
Period of Report
2021-11-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_163650879969132.html 4  
1 FORM 4 wf-form4_163650879969132.xml 4 4180
  Complete submission text file 0001169245-21-000112.txt   5800
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Issuer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PHASEBIO PHARMACEUTICALS, INC. 1 GREAT VALLEY PARKWAY, SUITE 30 MALVERN PA 19355
Business Address
Birchall Jonathan (Reporting) CIK: 0001892776 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38697 | Film No.: 211394029